| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |